SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Exacctnt who wrote (673)2/11/2000 1:26:00 AM
From: Exacctnt  Read Replies (1) of 1298
 
Abgenix shares offered at $210 each.
biz.yahoo.com

CEGE will receive cash amounting to $176.4 Million as a result of selling 840,000 shares of ABGX at $210 per share. They'll have cash coming out of the wazoo. CEGE will still own approximately 2 million shares of ABGX after the offering.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext